IC50 values of brivanib and its enantiomer for inhibition of VEFGR-2 and FGFR-1 kinases and for proliferation inhibition of HUVECs stimulated with growth factors
↵a IC50 values of brivanib were similar to those reported previously (Bhide et al., 2006).